| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/22/2010 | US20100184677 Use of the human pancreatic polypeptide as a therapeutic agent |
| 07/22/2010 | US20100184676 Use of a peptide as a therapeutic agent |
| 07/22/2010 | US20100184675 Use of glucagon (1-29) alone or in combination with neuropeptide w30 as a therapeutic agent |
| 07/22/2010 | US20100184674 Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent |
| 07/22/2010 | US20100184673 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent |
| 07/22/2010 | US20100184671 Binding molecules for the treatment of myeloid cell malignancies |
| 07/22/2010 | US20100184668 method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 07/22/2010 | US20100184667 Modified plasminogen activator inhibitor type-1 molecule and methods based thereon |
| 07/22/2010 | US20100184661 Conjugate comprising angiostation or its fragment, the method for producing the conjugate and use thereof |
| 07/22/2010 | US20100184652 Peptide inhibitors of abl kinases |
| 07/22/2010 | US20100184651 Targeted fusion proteins for cancer therapy |
| 07/22/2010 | US20100184646 Melanocortin receptor ligands modified with hydantoin |
| 07/22/2010 | US20100184645 Stitched polypeptides |
| 07/22/2010 | US20100184636 Method of Regulating Mammalian Target-of-Rapamycin Activity by Interaction Between Phospholipase D and Raptor |
| 07/22/2010 | US20100184215 Modified thioredoxin |
| 07/22/2010 | US20100183749 Topically active steroids for use in radiation and chemotherapeutics injury |
| 07/22/2010 | US20100183743 Benzthiazole inhibitors of poly(adp-ribose)polymerase |
| 07/22/2010 | US20100183742 Phosphoramidate alkylator prodrugs for the treatment of cancer |
| 07/22/2010 | US20100183740 Potent Inhibitory Effect of Zinc in Combination with Sulforaphane on Cancer Cell Growth |
| 07/22/2010 | US20100183728 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 07/22/2010 | US20100183726 Compositions and methods for treating cancer with dacarbazine nanoemulsions |
| 07/22/2010 | US20100183713 Gastrointestinal-specific multiple drug release system |
| 07/22/2010 | US20100183705 Phospholipid-analogous compounds |
| 07/22/2010 | US20100183702 Therapies For Cancer Using RLIP76 |
| 07/22/2010 | US20100183685 Tumor and infectious disease therapeutic compositions |
| 07/22/2010 | US20100183650 Antigen Delivery Vectors and Constructs |
| 07/22/2010 | US20100183643 Cancer vaccines containing epitopes of oncofetal antigen |
| 07/22/2010 | US20100183642 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 07/22/2010 | US20100183637 fusion molecule based on novel taa variant |
| 07/22/2010 | US20100183635 Glycosylated specificity exchangers |
| 07/22/2010 | US20100183632 Antibody Therapy For Modulating Function Of Intestinal Receptors |
| 07/22/2010 | US20100183631 Antibodies Directed to HER-3 and Uses Thereof |
| 07/22/2010 | US20100183630 Tat-005 and Methods of Assessing and Treating Cancer |
| 07/22/2010 | US20100183621 Fully human antibodies against human 4-1BB |
| 07/22/2010 | US20100183616 Antibodies against interleukin-1 beta |
| 07/22/2010 | US20100183615 Cross-species-specific bispecific binders |
| 07/22/2010 | US20100183612 Methods of treatment using ctla4 mutant molecules |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/22/2010 | US20100183606 Monocyclic heterocycles as kinase inhibitors |
| 07/22/2010 | US20100183604 Preventive/remedy for cancer |
| 07/22/2010 | US20100183603 Compositions and Methods for the Treatment of Cancer |
| 07/22/2010 | US20100183601 Combination of Aurora Kinase Inhibitors and Anti-CD20 Antibodies |
| 07/22/2010 | US20100183600 RAF Inhibitors and Their Uses |
| 07/22/2010 | US20100183599 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 07/22/2010 | US20100183595 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
| 07/22/2010 | US20100183594 Steroid-sparing methods of treating brain edema |
| 07/22/2010 | US20100183593 Gene Polymorphisms Predictive for Dual TKI Therapy |
| 07/22/2010 | US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines |
| 07/22/2010 | US20100183585 Methods and compositions for treating tumors and metastases through the modulation of latexin |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183573 membrane polypeptide for use in designing therapeutic for proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders; cancer, immunological-related, blood-related and skin-related disorders |
| 07/22/2010 | US20100183570 Non-embryonic stem cells and uses thereof |
| 07/22/2010 | US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof |
| 07/22/2010 | US20100183564 Compounds that expand hematopoietic stem cells |
| 07/22/2010 | US20100183560 Angiogenesis-modulating compositions and uses |
| 07/22/2010 | US20100183558 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules |
| 07/22/2010 | US20100183550 Benzothienopyridines For Use As Inhibitors Of EG5 Kinesin |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183545 Targeted cargo protein combination therapy |
| 07/22/2010 | US20100183544 Method of treatment |
| 07/22/2010 | US20100183542 Synergism Between Activated Immune Cells and Conventional Cancer Therapies |
| 07/22/2010 | US20100183517 Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods Of Use |
| 07/22/2010 | US20100183511 Small peptides specifically bind to colorectal cancers |
| 07/22/2010 | US20100183508 Radioactive mixture and manufacturing method thereof |
| 07/22/2010 | US20100183507 Tumor markers in ovarian cancer |
| 07/22/2010 | US20100183506 Antigen associated with lung cancers and lymphomas |
| 07/22/2010 | US20100183505 Immunoconjugate for human cd66 for the treatment of multiple myeloma and other haematological malignancies |
| 07/22/2010 | US20100183504 Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics |
| 07/22/2010 | DE102009005193A1 Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren New heterocyclic compounds as MetAP-2 inhibitors |
| 07/22/2010 | CA2758030A1 Malate salt of n-(4-{[6,7-bis(methyloxy)quin0lin-4-yl]oxy}phenyl-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer |
| 07/22/2010 | CA2750009A1 Imidazothiazole derivatives having proline ring structure |
| 07/22/2010 | CA2749496A1 Compositions and methods of use |
| 07/22/2010 | CA2747837A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | CA2747835A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/21/2010 | EP2208784A1 Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 07/21/2010 | EP2208737A1 Complement factor H-derived short consensus repeat-antibody constructs |
| 07/21/2010 | EP2208731A1 Process for preparation of 1,2-diamino-cyclohexane-platinum(II) complexes |
| 07/21/2010 | EP2208725A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/21/2010 | EP2208721A1 Histone deacetylase inhibitor, composition and use thereof |
| 07/21/2010 | EP2208499A1 Nucleic acid capable of regulating the proliferation of cell |
| 07/21/2010 | EP2208497A1 Use of Ursodeoxycholic acid (UDCA) for enhancing the general health condition of a tumor patient |
| 07/21/2010 | EP2207875A1 Antigen-specific t-cell preparations from bone marrow |
| 07/21/2010 | EP2207819A1 Anti-microbial polymers and their compositions |
| 07/21/2010 | EP2207810A1 Compositions affecting hyaluronic acid mediated activity |
| 07/21/2010 | EP2207809A1 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 07/21/2010 | EP2207803A1 Cd9-specific human antibodies |
| 07/21/2010 | EP2207791A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 07/21/2010 | EP2207786A1 2 ' -flu0r0-2 ' -deoxytetrahydrouridines as cytidine deaminase inhibitors |
| 07/21/2010 | EP2207781A1 Thiazolopyrimidine p13k inhibitor compounds and methods of use |
| 07/21/2010 | EP2207777A2 Polymorphs of dasatinib and process for preparation thereof |
| 07/21/2010 | EP2207774A1 Triazole derivatives as scd inhibitors |
| 07/21/2010 | EP2207772A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| 07/21/2010 | EP2207562A1 Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion |
| 07/21/2010 | EP2207560A2 Use of fibronectin fragment (196-203) as a therapeutic agent |
| 07/21/2010 | EP2207548A1 Breast cancer therapy |
| 07/21/2010 | EP2068894B1 Use of cis-rhenium (iii) diadamantate compounds for potentiating the antitumoral activity of platinium complexes |
| 07/21/2010 | EP1940840B1 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 07/21/2010 | EP1809622B1 Inhibitors of the interaction between mdm2 and p53 |
| 07/21/2010 | EP1751128B1 Chromene-derivatives with anti-tubulin and vascular targeting activity |
| 07/21/2010 | EP1742623B1 2-methylthiazolidine-2,4-dicarboxylic acid-containing combination preparations |